|
Nitsch, Doris and Boshart, Michael and Schütz, Günther
(1993):
Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements.
In: Proceedings of the National Academy of Science of the USA, Vol. 90, No. 12: pp. 5479-5483
|
![[img]](http://epub.ub.uni-muenchen.de/3212/1.hassmallThumbnailVersion/016.pdf)  Preview |
|
PDF
1469Kb |
Abstract
Tyrosine aminotransferase (TAT; L-tyrosine:
2-oxoglutarate aminotransferase, EC 2.6.1.5) gene activity
is stimulated by glucocorticoids and glucagon and is repressed
by insulin. Expression and responsiveness to the different
signal transduction pathways are restricted to the liver,
in which the gene is activated shortly after birth. Here we
provide a model for the basis of this tissue specificity of the
hormonal control. In the two enhancers mediating hormone
induction of TAT gene activity we find the hormone response
elements in combination with binding sites for constitutive
liver-enriched transcription factors: proteins of the hepatocyte
nuclear factor 3 family bind in the vicinity of the glucocorticoid
response element located 2.5 kb upstream of the transcription
start site, while hepatocyte nuclear factor 4 interacts with an
essential element in the cAMP-responsive enhancer at -3.6 kb.
By juxtaposing the liver-specific element and the target sequence
of the signal transduction pathway the regulatory
properties of either enhancer can be reconstituted. Thus, the
interdependence of the respective enhancer motifs restricts the
hormonal activation of the TAT gene to the liver. The coincidence
of the onset ofTAT gene expression around birth with the
perinatal changes in the concentrations of glucocorticoids,
glucagon, and insulin suggests cooperation of signal transduction
pathways and cell type-specific transcription factors in the
developmental activation of the TAT gene.